Exact Mass: 394.1522
Exact Mass Matches: 394.1522
Found 500 metabolites which its exact mass value is equals to given mass value 394.1522
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Gibberellin A43
Gibberellin A43 (GA43) belongs to the class of organic compounds known as C20-gibberellin 20-carboxylic acids. These are C20-gibberellins with a carboxyl group at the 6-position. Gibberellin A43 is found in common pea. Gibberellin A43 is from Cucurbita maxim. From Cucurbita maxima. Gibberellin A43 is found in many foods, some of which are common pea, japanese pumpkin, winter squash, and fruits.
Gibberellin A39
Gibberellin A39 (GA39) belongs to the class of organic compounds known as C20-gibberellin 20-carboxylic acids. These are C20-gibberellins with a carboxyl group at the 6-position. Gibberellin A39 is found in fruits. Gibberellin A39 is a constituent of the seeds of Cucurbita pepo and Cucurbita maxima. Constituent of the seeds of Cucurbita pepo and Cucurbita maxima. Gibberellin A39 is found in winter squash, fruits, and japanese pumpkin.
1-(3-Methyl-2-butenoyl)-6-apiosylglucose
1-(3-Methyl-2-butenoyl)-6-apiosylglucose is found in coffee and coffee products. 1-(3-Methyl-2-butenoyl)-6-apiosylglucose is a constituent of green coffee beans (Coffea arabica). Constituent of green coffee beans (Coffea arabica). 1-(3-Methyl-2-butenoyl)-6-apiosylglucose is found in coffee and coffee products.
Loteprednol
Loteprednol (as Loteprednol Etabonate) is a topical corticoid antiinflammatory. It is used in ophthalmic solution for the treatment of steroid responsive inflammatory conditions of the eye such as allergic conjunctivitis, uveitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, and selected infective conjunctivitides. As a nasal spray, is used for the treatment and management of seasonal allergic rhinitis. S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018926 - Anti-Allergic Agents
Pyro(l-alpha-aminoadipyl)-L-histidyl-L-thiazolidine-4-carboxamide
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
4-Hydroxymethyl Ambrisentan
Varespladib methyl
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors C471 - Enzyme Inhibitor Varespladib methyl (A-002; LY333013) is a selective inhibitor of group II secretory phospholipase A2 (PLA2).
Gibberellin A28
Gibberellin a28 is a member of the class of compounds known as c20-gibberellin 20-carboxylic acids. C20-gibberellin 20-carboxylic acids are c20-gibberellins with a carboxyl group at the 20-position. Gibberellin a28 is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Gibberellin a28 can be found in japanese pumpkin, scarlet bean, and winter squash, which makes gibberellin a28 a potential biomarker for the consumption of these food products.
Dehydrodihydrorotenone
2,4,5-Trimethoxy-2,2-dimethylpyrano[5,6:6,7]isoflavone
3,4-Dihydroxy-7-methoxy-8-prenyl-5-(2-hydroxyisopropyl)-[2,3:5,6]furanoflavanone
[3aS-[3aR*,4R*(Z),5R*,6R*,9S*,10E,11aS*]]-2-Methyl-, 2,3,3a,4,5,6,7,8,9,11a-decahydro-5,6,9-trihydroxy-6,10-dimethyl-3-methylene-2,7-dioxocyclodeca[b]furan-4-yl ester 2-butenoic acid
(E)-3,4-Methylenedioxy-2-methoxy-6,6-dimethylchromeno-[2,3:4,3]-9-methoxychalcone
8-C-Methylvellokaempferol 3,5-dimethyl ether
1-(4-Hydroxy-3-methoxy)-phenyl-2-[4-(2,3-dihydroxypropyl)-2-methoxy]-phenoxy-1,3-propandiol
5,7,10-trihydroxy-2,2-dimethyl-12-(3-methylbut-2-enyl)pyrano[3,2-b]xanthen-6-one
Muxiangrin I
(Z)-3,4-Methylenedioxy-2-methoxy-6,6-dimethylchromeno-[2,3:4,3]-9-methoxychalcone
Purpurin
Purpurin is a naturally occurring organic compound that belongs to the anthraquinone family. It is known for its distinctive red color and is found in various plants, particularly in the bark and roots of certain trees, as well as in some soil bacteria. The compound has a long history of use as a natural dye, especially in ancient times for coloring fabrics and as a component in inks. Chemically, Purpurin is characterized by a structure consisting of three fused benzene rings forming an anthraquinone skeleton, with two carboxylic acid groups attached to two of the benzene rings. This structure is responsible for its color and chemical properties. The presence of the carboxylic acid groups makes Purpurin soluble in alkaline solutions, which is why it was historically used in dyeing processes. In addition to its historical use as a dye, Purpurin has also found applications in modern science. It has been used as a fluorescent marker in biological and medical research due to its ability to absorb light at specific wavelengths and emit fluorescence. This property makes it useful in techniques such as fluorescence microscopy and imaging. Moreover, Purpurin and its derivatives have been studied in the fields of pharmacology and materials science. The compound's unique chemical structure and properties have made it a subject of interest for developing new pharmaceuticals and advanced materials. Its natural occurrence and the potential for sustainable synthesis from plant sources also contribute to its relevance in modern chemistry and related disciplines.
Samaderine Z
A quassinoid isolated from Quassia indica and has been shown to exhibit antimalarial and antineoplastic activity.
Rotenone
Origin: Plant, Pyrans relative retention time with respect to 9-anthracene Carboxylic Acid is 1.283 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.281 Acquisition and generation of the data is financially supported by the Max-Planck-Society D004791 - Enzyme Inhibitors > D014475 - Uncoupling Agents D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals IPB_RECORD: 2241; CONFIDENCE confident structure Rotenone is a mitochondrial electron transport chain complex I inhibitor. Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. Rotenone is a mitochondrial electron transport chain complex I inhibitor. Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. Rotenone is a mitochondrial electron transport chain complex I inhibitor. Rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production.
(2E,8S,10R)-10,11-Dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl methacrylate
1,6,7-trihydroxy-6,6-dimethyl-2H-pyrano(2,3:3,2)-4-(3-methylbut-2-enyl)xanthone
A member of the class of pyranoxanthones that is 2H,6H-pyrano[3,2-b]xanthen-6-one substituted by hydroxy groups at positions 5, 8 and 9, geminal methyl groups at position 2 and a prenyl group at position 12. Isolated from Garcinia lancilimba, it exhibits inhibitory effects on human cancer cell line.
4-(6-O-trans-cinnamoyl)-(2-hydroxymethyl)-4-hydroxybutenyl-beta-D-glucopyranoside
(+)-purpurin|(+)-Purpurin 2|7a,10,10a-Triepimer -Purpurin+
8alpha-propionyloxyanthemolide C|8??-Propionyloxyanthemolide C
samaderine E
A quassinoid isolated from Quassia indica and Samadera indica and has been shown to exhibit antimalarial and cytotoxic activities.
4,5-dihydro-1,5-dihydroxy-6,6-dimethylpyrano(2,3:6,7)-4,4,5-trimethylfurano(2,3:3,4)xanthone
5,10-dihydroxy-12-((Z)-3-hydroxymethylbut-2-enyl)-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one|garcinexanthone E
2-(trans-cinnamoyloxy-methyl)-1-butene-4-O-beta-D-glucopyranoside
(2R,3R,4R,4aS,5R,5aS,7R,9R,12aR,12bS)-4,7,10-trihydroxy-5-methoxy-2,7,9-trimethyl-12-oxo-1,2,3,4,4a,5,5a,6,7,8,9,11,12a,12b-tetradecahydrobenzo[g]cycloocta[cd]pentalene-6,11-dione|abyssomicin E
N-[1-Acetyl-2-(1,3-benzodioxole-5-ylcarbonyl)-3-phenylpyrrolidine-4-yl]acetamide
1,4,6-trihydroxy-5-(1,1-dimethyl-2-propenyl)-6,6-dimethylpyrano[2,3:3,2]xanthone|soulattrin
(7S,8R)-4,7,9,9-tetrahydroxy-3,3-dimethoxy-8-O-4-neolignan
4,2?,4?trihydroxy-6?-methoxy-3?(2??-hydroxybenzyl)dihydrochalcone
2-methyl-5-(2-hydroxypropy1)-7-hydroxychromone-2-O-D-glucopyranoside
2-(2,4-dihydroxyphenyl)-3-(3,5-dihydroxyphenyl)-7-hydroxy-4,4-dimethylchromane|4-[3-(3,5-dihydroxyphenyl)-3,4-dihydro-7-hydroxy-4,4-dimethyl-2H-1-benzopyran-2-yl]benzene-1,3-diol|artoxanthochromane
8alpha-(2,3-epoxy-2-methylbutyryloxy)-4alpha,9alpha-epidioxy-9beta-hydroxy-5betaH-eudesm-1-en-6beta,12-olide
10-(1,1-Dimethyl-2-propenyl)-7,9,12-trihydroxy-2,2-dimethyl-2H,6H-pyrano[3,2-b]xanthen-6-one|macluraxanthone
5,9,10-trihydroxy-2,2-dimethyl-12-(3-methylbut-2-enyl)pyrano[3,2-b]xanthen-6-one
methyl 11,12-methylenedioxy-N(1)-decarbomethoxy-Delta14,15-chanofruticosinate|methyl 11,12-methylenedioxy-N-decarbomethoxy-Delta14,15-chanofruticosinate|Methyl 11,12-methylenedioxy-N1-decarbomethoxy-Delta14,15-chanofruticosinate|methyl 11,12-methylenedioxy-N1-decarbomethoxy-Delta14,15chanofruticosinate
(E)-3-{2,3-dihydro-2-[2-[(E)-p-coumaroyloxy]-1-methylethyl]-5-benzofuranyl}-2-propenoic acid
2alpha-tigloyloxy-3,8-dioxo-11-peroxy-4beta,5beta,7alpha,14-bis-epoxybisabol-9E-ene
1-(4-Hydroxy-3-methoxyphenyl)-2-[4-(2,3-dihydroxypropyl)-2-methoxyphenoxy]-1,3-propanediol
5-hydroxy-7-methoxy-8-methyl-3,4-methylenedioxy-5-(3-methyl-but-2-enyl)-3,4-methylenedioxyflavone
8beta-(2-methyl-2,3-epoxybutyryloxy)-5,9beta-dihydroxytrichosalviolide|8beta-<2-methyl-2,3-epoxybutyryloxy>-5,9beta-dihydroxytrichosalviolide
1,5,6-trihydroxy-6,6-dimethyl-2H-pyrano(2,3:3,4)-2-(3-methylbut-2-enyl)xanthone
A member of the class of pyranoxanthones that is 3H,7H-pyrano[2,3-c]xanthen-7-one substituted by hydroxy groups at positions 6, 10 and 11, geminal methyl groups at position 3 and a prenyl group at position 5. Isolated from Garcinia lancilimba, it exhibits inhibitory effects on human cancer cell line.
1alpha-hydroperoxy-4alpha,10alpha-dihydroxy-9alpha-angeloyloxyguaia-2,11(13)-dien-12,6alpha-olide
5,9,10-trihydroxy-2,2-dimethyl-12-(2-methylbut-3-en-2-yl)pyrano[3,2-b]xanthen-6-one
8,8-dimethyl-3-(2,4,5-trimethoxyphenyl)pyrano[2,3-f]chromen-4-one
C21H27ClO5_6H-2-Benzopyran-6-one, 8-(acetyloxy)-5-chloro-3-[(1E,3E,5S)-3,5-dimethyl-1,3-heptadien-1-yl]-1,7,8,8a-tetrahydro-7-hydroxy-7-methyl-, (7R,8R,8aR)
C20H26O8_2-Propenoic acid, 2-methyl-, (4S,6R,11E)-2,4,5,6,7,8,9,10-octahydro-6,7-dihydroxy-3-(methoxymethyl)-6,10-dimethyl-2-oxo-7,10-epoxycyclodeca[b]furan-4-yl ester
(1R,2E,8S,10R,11S)-10,11-dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate
8,8-dimethyl-3-(2,4,5-trimethoxyphenyl)pyrano[2,3-f]chromen-4-one [IIN-based: Match]
8,8-dimethyl-3-(2,4,5-trimethoxyphenyl)pyrano[2,3-f]chromen-4-one [IIN-based on: CCMSLIB00000848572]
(1R,2E,8S,10R,11S)-10,11-dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate_major
(1R,2E,8S,10R,11S)-10,11-dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate_34.9\\%
(1R,2E,8S,10R,11S)-10,11-dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,?]tetradeca-2,6-dien-8-yl 2-methylprop-2-enoate
Ala Cys Thr Thr
Ala Met Ser Ser
Ala Ser Met Ser
Ala Ser Ser Met
Ala Thr Cys Thr
Ala Thr Thr Cys
Cys Ala Thr Thr
Cys Ser Ser Val
Cys Ser Val Ser
Cys Thr Ala Thr
Cys Thr Thr Ala
Cys Val Ser Ser
Asp Phe Gly Gly
Asp Gly Phe Gly
Asp Gly Gly Phe
Phe Asp Gly Gly
Phe Gly Asp Gly
Gly Asp Phe Gly
Gly Asp Gly Phe
Gly Phe Asp Gly
Gly Gly Asp Phe
Gly Met Ser Thr
Gly Met Thr Ser
Gly Ser Met Thr
Gly Ser Thr Met
Gly Thr Met Ser
Gly Thr Ser Met
Met Ala Ser Ser
Met Gly Ser Thr
Met Gly Thr Ser
Met Ser Ala Ser
Met Ser Gly Thr
Met Ser Ser Ala
Met Ser Thr Gly
Met Thr Gly Ser
Met Thr Ser Gly
Ser Ala Met Ser
Ser Ala Ser Met
Ser Cys Ser Val
Ser Cys Val Ser
Ser Gly Met Thr
Ser Gly Thr Met
Ser Met Ala Ser
Ser Met Gly Thr
Ser Met Ser Ala
Ser Met Thr Gly
Ser Ser Ala Met
Ser Ser Cys Val
Ser Ser Met Ala
Ser Ser Val Cys
Ser Thr Gly Met
Ser Thr Met Gly
Ser Val Cys Ser
Ser Val Ser Cys
Thr Ala Cys Thr
Thr Ala Thr Cys
Thr Cys Ala Thr
Thr Cys Thr Ala
Thr Gly Met Ser
Thr Gly Ser Met
Thr Met Gly Ser
Thr Met Ser Gly
Thr Ser Gly Met
Thr Ser Met Gly
Thr Thr Ala Cys
Thr Thr Cys Ala
Val Cys Ser Ser
Val Ser Cys Ser
Val Ser Ser Cys
(2S,7aR,10S,10aS)-9,9-Dimethyl-4-oxo-2-phenyl-3,4,7a,9,10,10a-hexahydro-2H-furo[3,2:4,5]furo[2,3-h]chromen-10-yl acetate
loteprednol
S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018926 - Anti-Allergic Agents
garcinone B
Gibberellin A39
Gibberellin A43
1-(3-Methyl-2-butenoyl)-6-apiosylglucose
Ethyl 4-acetoxy-8-(benzyloxy)-7-methoxy-2-naphthoate
N-(4-methoxyphenyl)-N-[1-[3-(trifluoromethyl)phenyl]propan-2-yl]propanediamide
3-indol-1-ylsulfonyl-7-(4-methylpiperazin-1-yl)-1H-indole
5-fluoro-o4-(2,4,6-trimethylphenyl)-2-o-methyluridine
1-Piperidineaceticacid,3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-2-oxo-(9CI)
2-[4-(2-methylpropyl)phenyl]-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
2-(4-AMINOPHENYL)-7-(2-MORPHOLIN-4-YL-ETHOXY)IMIDAZO[2,1-B]-[1,3]BENZOTHIAZOLE
Hdac inhibitor CHR-3996
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Aminopentamide Sulfate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Bisphenol A (3-chloro-2-hydroxypropyl) (2,3-dihydroxypropyl) ether
2-[[5-(4-Methylphenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(4-phenyl-1-piperazinyl)ethanone
5-[2-Furanyl-[4-(phenylmethyl)-1-piperidinyl]methyl]-6-thiazolo[3,2-b][1,2,4]triazolol
(1)Benzopyrano(3,4-b)furo(2,3-h)(1)benzopyran-6(6aH)-one, 12,12a-dihydro-2-isopropyl-8,9-dimethoxy-, (+)-
N-(3-Cyanophenyl)-2-Methyl-5-(5-Methyl-1,3,4-Oxadiazol-2-Yl)-4-Biphenylcarboxamide
Varespladib methyl
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors C471 - Enzyme Inhibitor Varespladib methyl (A-002; LY333013) is a selective inhibitor of group II secretory phospholipase A2 (PLA2).
[10,11-Dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] 2-methylprop-2-enoate
5,6-Dihydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylic acid
5,11-Dihydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4,8-tricarboxylic acid
N-(4-methyl-2-pyridinyl)-4-[3-(trifluoromethyl)anilino]-1-piperidinecarbothioamide
2-(4-methoxyanilino)-7-oxo-N-(2-oxolanylmethyl)-1-benzopyran-3-carboxamide
1-Methyl-4-[[2-oxo-2-[4-(2-pyridinyl)-1-piperazinyl]ethyl]thio]-2-quinolinone
Pyridin-3-ylmethyl {4-[(2-amino-4-fluorophenyl)carbamoyl]benzyl}carbamate
2-[[4-[(1-Methyl-2-oxo-4-quinolinyl)oxy]-1-oxobutyl]amino]benzoic acid methyl ester
3-benzyl-5-(4-hydroxyphenyl)-N-(phenylacetyl)pyrazin-2-aminide
2-pyridin-3-yl-1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one
[(2E)-10,11-dihydroxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] 2-methylprop-2-enoate
A-674563 (hydrochloride)
A-674563 hydrochloride is a potent and selective Akt1 inhibitor with Ki of 11 nM.
5,9,10-trihydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
(1s,2r,7r,9r,13r,14s,15r,16s,17r)-14,15,16-trihydroxy-4-methoxy-2,14,17-trimethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-ene-3,6,11-trione
1,12-dihydroxy-2-(hydroxymethyl)-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl 2-methylbut-2-enoate
(1s,2z,4s,8r,9r,11s,12r)-1,12-dihydroxy-2-(hydroxymethyl)-11-methyl-7-methylidene-6-oxo-5,14-dioxatricyclo[9.2.1.0⁴,⁸]tetradec-2-en-9-yl (2z)-2-methylbut-2-enoate
(2s,3r,4s,5s,6r)-2-{[(1r,4r,5r,6s,7r,8s,9s)-4,5-dihydroxy-6-methoxy-2,10-dioxatricyclo[5.3.1.0⁴,⁸]undecan-9-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
8-hydroxy-4,9-dimethyl-14-methylidene-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradec-9-en-2-yl 4-hydroxy-2-(hydroxymethyl)but-2-enoate
5,8,9-trihydroxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
7,9,12-trihydroxy-2,2-dimethyl-10-(3-methylbut-2-en-1-yl)-1,11-dioxatetracen-6-one
(6s)-10,21-dihydroxy-5,5,6,18,18-pentamethyl-2,7,19-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1(21),3,8,10,13,15(20),16-heptaen-12-one
(2s)-7-(4-hydroxyphenyl)-4,6-dimethoxy-9-methyl-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(2r)-7-(4-hydroxyphenyl)-4,6-dimethoxy-9-methyl-2-(prop-1-en-2-yl)-2h,3h-furo[3,2-g]chromen-5-one
(3s,8s,9s,11e)-8,9,16-trihydroxy-13,14-dimethoxy-3-methyl-4,5,6,8,9,10-hexahydro-3h-2-benzoxacyclotetradecine-1,7-dione
2-hydroxy-2-methyl-1-{4-oxo-2-phenyl-8h,9h-furo[2,3-h]chromen-9-yl}propyl acetate
5,12-dihydroxy-2,2,10,10-tetramethyl-3,4-dihydro-1,11,13-trioxapentacen-6-one
6,8,12-trihydroxy-2,2-dimethyl-9-(2-methylbut-3-en-2-yl)-1,10-dioxatetraphen-5-one
(1s,2r)-1-(4-hydroxy-3-methoxyphenyl)-2-[2-hydroxy-4-(3-hydroxypropyl)-6-methoxyphenoxy]propane-1,3-diol
5,10,13,14,15-pentahydroxy-4,12,16-trimethyl-3,8-dioxapentacyclo[9.8.0.0¹,⁵.0⁴,⁹.0¹²,¹⁷]nonadeca-16,18-dien-7-one
(1r)-2-hydroxy-2-methyl-1-[(9r)-4-oxo-2-phenyl-8h,9h-furo[2,3-h]chromen-9-yl]propyl acetate
(11r)-11-(3,4-dihydroxyphenyl)-7-methoxy-8-(3-methylbut-2-en-1-yl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,4,6,8-tetraen-13-one
(3as,4r,5r,6s,6ar,8r,9bs)-5-(acetyloxy)-6,8-dihydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-4-yl propanoate
7,9,12-trihydroxy-2,2-dimethyl-8-(2-methylbut-3-en-2-yl)-1,11-dioxatetracen-6-one
(2r)-6,9,11-trihydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)-1,5-dioxatetraphen-10-one
methyl (1r,2r,4r,5r,7r,12s,15s,23r)-4-hydroxy-3-oxo-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17,19,21-triene-16-carboxylate
(3s,8s,9r,11e)-8,9,16-trihydroxy-13,14-dimethoxy-3-methyl-4,5,6,8,9,10-hexahydro-3h-2-benzoxacyclotetradecine-1,7-dione
3-[(1r,7s,8s,9r)-7-(acetyloxy)-4-(methoxycarbonyl)-9-methyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]propanoic acid
5-chloro-3-[(1e,3e)-3,5-dimethylhepta-1,3-dien-1-yl]-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1h-isochromen-8-yl acetate
(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl 3-methylbut-2-enoate
3-[(3,7-dimethyl-6-oxoocta-2,7-dien-1-yl)oxy]-1,7-dihydroxyxanthen-9-one
(3as,4r,6ar)-6a-[2-(2,5-dihydroxyphenyl)-2-oxoethyl]-3a-(dimethoxymethyl)-4-ethoxy-tetrahydrocyclopenta[c]furan-1-one
(7r,8r,8ar)-5-chloro-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1h-isochromen-8-yl acetate
2,10-dihydroxy-1,10-dimethyl-6-methylidene-5,11-dioxo-4,14-dioxatricyclo[7.4.1.0³,⁷]tetradecan-8-yl 2-methylbut-2-enoate
6,8,11-trihydroxy-2,2-dimethyl-12-(3-methylbut-2-en-1-yl)-1,5-dioxatetraphen-10-one
(1r,14r)-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁵,²⁰]docosa-3,5,9,11,15(20),16,18-heptaen-13-one
n-[(3s,4s,5s)-1-acetyl-5-(2h-1,3-benzodioxole-5-carbonyl)-4-phenylpyrrolidin-3-yl]ethanimidic acid
3-methylbut-2-enoyl-1-o-β-d-glucopyranosyl-β-d-apiofuranoside
{"Ingredient_id": "HBIN008910","Ingredient_name": "3-methylbut-2-enoyl-1-o-\u03b2-d-glucopyranosyl-\u03b2-d-apiofuranoside","Alias": "NA","Ingredient_formula": "C16H26O11","Ingredient_Smile": "CC(=CC(=O)OC1C(C(C(C(O1)COC2C(C(CO2)(CO)O)O)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14171","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7,4'-trihydroxy-6-(3,3-dimethylallyloxiranyl-methyl)isoflavone
{"Ingredient_id": "HBIN011218","Ingredient_name": "5,7,4'-trihydroxy-6-(3,3-dimethylallyloxiranyl-methyl)isoflavone","Alias": "NA","Ingredient_formula": "C23H22O6","Ingredient_Smile": "CC(=CCC(C1CO1)C2=C(C3=C(C=C2O)OC=C(C3=O)C4=CC=C(C=C4)O)O)C","Ingredient_weight": "394.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21700","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "129716149","DrugBank_id": "NA"}
anticancersimaroubolide pmv70p 691-137
{"Ingredient_id": "HBIN016357","Ingredient_name": "anticancersimaroubolide pmv70p 691-137","Alias": "NA","Ingredient_formula": "C20H26O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14325","TCMID_id": "1441","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}